Skip to content
Exploring Machine Learning, AI, and Data Science

Posts by Frank La Vigne

Geoff Thatcher on How AI is Revolutionizing Storytelling

Joining hosts Frank La Vigne and Andy Leonard, Geoff shares insights on the intersection of AI and creativity, the evolving landscape of careers in the age of artificial intelligence, and the crucial balance between innovation and traditional storytelling. We’ll delve into AI’s role in enhancing emotional connections with audiences, its potential to disrupt traditional media…

Alex Gold on DevOps for Data Science and Open Source Practices

Frank La Vigne sits down with Alex Gold, Head of Solutions Engineering at POSIT and author of “DevOps for Data Science.” Together, they explore the fascinating intersections of DevOps, MLOps, and generative AI, shedding light on the importance of social norms, innovation, and practical impact in open-source development. Show Notes Links DevOps for Data Science…

David Hirschfeld on Creating High-Impact Teams & Validating Niches

Today, Frank and Andy are joined by David Hirschfeld, CEO and founder of Tekyz Corporation, a firm specializing in helping startups and saving troubled projects with his unique “Launch First” methodology. David brings us into his world of startups, where, believe it or not, he advocates for getting customers before you even build the product!…

Candace Gillhoolley on AI and Data Driven Marketing Strategies

Today, we have a special treat for you as we welcome Candice Gillhooley, a dynamic force known for blending technical prowess with marketing brilliance. In this episode, we’ll explore Candice’s groundbreaking approach to “sentient marketing,” dive into the interplay between AI and targeted audience communication, and discuss the importance of understanding behavioral data to craft…

Baruch Lev and Feng Gu on Data Driven Mergers and Why Most Deals Fail

Andy Leonard and Frank La Vigne are joined by experts Baruch Lev and Feng Gu to uncover the complexities and pitfalls of mergers and acquisitions. We’ll discuss the controversial “killer acquisitions” in the pharmaceutical industry, which regulators fear stifle innovation and harm public health. Our guests will share insights from their upcoming book, “The M&A…